| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.01 |